These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 17003506)

  • 1. NKR-P1 biology: from prototype to missing self.
    Mesci A; Ljutic B; Makrigiannis AP; Carlyle JR
    Immunol Res; 2006; 35(1-2):13-26. PubMed ID: 17003506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors.
    Carlyle JR; Jamieson AM; Gasser S; Clingan CS; Arase H; Raulet DH
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3527-32. PubMed ID: 14990792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional requirements for signaling through the stimulatory and inhibitory mouse NKR-P1 (CD161) NK cell receptors.
    Ljutic B; Carlyle JR; Filipp D; Nakagawa R; Julius M; Zúñiga-Pflücker JC
    J Immunol; 2005 Apr; 174(8):4789-96. PubMed ID: 15814704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse Cytomegalovirus m153 Protein Stabilizes Expression of the Inhibitory NKR-P1B Ligand Clr-b.
    Aguilar OA; Sampaio IS; Rahim MMA; Samaniego JD; Tilahun ME; Krishnamoorthy M; Popović B; Babić M; Krmpotić A; Treanor B; Margulies DH; Allan DSJ; Makrigiannis AP; Jonjić S; Carlyle JR
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity.
    Bezouska K; Yuen CT; O'Brien J; Childs RA; Chai W; Lawson AM; Drbal K; Fiserová A; Pospísil M; Feizi T
    Nature; 1994 Nov; 372(6502):150-7. PubMed ID: 7969447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and comparison of the lytic function of NKR-P1+ and NKR-P1-rat natural killer cell clones established from NKR-P1bright/TCR alpha beta-cell lines.
    Brissette-Storkus C; Appasamy PM; Hayes LA; Kaufman CL; Ildstad ST; Chambers WH
    Nat Immun; 1995; 14(2):98-113. PubMed ID: 8601077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity.
    Ryan JC; Niemi EC; Nakamura MC; Seaman WE
    J Exp Med; 1995 May; 181(5):1911-5. PubMed ID: 7722466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NKR-P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium.
    Ryan JC; Niemi EC; Goldfien RD; Hiserodt JC; Seaman WE
    J Immunol; 1991 Nov; 147(9):3244-50. PubMed ID: 1919012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association with FcRgamma is essential for activation signal through NKR-P1 (CD161) in natural killer (NK) cells and NK1.1+ T cells.
    Arase N; Arase H; Park SY; Ohno H; Ra C; Saito T
    J Exp Med; 1997 Dec; 186(12):1957-63. PubMed ID: 9396764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex.
    Yokoyama WM; Seaman WE
    Annu Rev Immunol; 1993; 11():613-35. PubMed ID: 8476574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cDNA cloning of mouse NKR-P1 and genetic linkage with LY-49. Identification of a natural killer cell gene complex on mouse chromosome 6.
    Yokoyama WM; Ryan JC; Hunter JJ; Smith HR; Stark M; Seaman WE
    J Immunol; 1991 Nov; 147(9):3229-36. PubMed ID: 1680927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic structure and strain-specific expression of the natural killer cell receptor NKR-P1.
    Giorda R; Weisberg EP; Ip TK; Trucco M
    J Immunol; 1992 Sep; 149(6):1957-63. PubMed ID: 1517565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mouse NKR-P1B:Clr-b recognition system is a negative regulator of innate immune responses.
    Rahim MM; Chen P; Mottashed AN; Mahmoud AB; Thomas MJ; Zhu Q; Brooks CG; Kartsogiannis V; Gillespie MT; Carlyle JR; Makrigiannis AP
    Blood; 2015 Apr; 125(14):2217-27. PubMed ID: 25612621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-evaluation of the involvement of NK cells and C-type lectin-like NK receptors in modulation of immune responses by multivalent GlcNAc-terminated oligosaccharides.
    Grobárová V; Benson V; Rozbeský D; Novák P; Cerný J
    Immunol Lett; 2013; 156(1-2):110-7. PubMed ID: 24076118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ablation of a specific cell population by the replacement of a uniquely expressed gene with a toxin gene.
    Arase K; Saijo K; Watanabe H; Konno A; Arase H; Saito T
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9264-8. PubMed ID: 10430931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of upstream cis-acting regulatory elements controlling lineage-specific expression of the mouse NK cell activation receptor, NKR-P1C.
    Ljutic B; Carlyle JR; Zúñiga-Pflücker JC
    J Biol Chem; 2003 Aug; 278(34):31909-17. PubMed ID: 12813047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor.
    Aldemir H; Prod'homme V; Dumaurier MJ; Retiere C; Poupon G; Cazareth J; Bihl F; Braud VM
    J Immunol; 2005 Dec; 175(12):7791-5. PubMed ID: 16339512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression cloning and function of the rat NK activating and inhibitory receptors NKR-P1A and -P1B.
    Li J; Rabinovich BA; Hurren R; Shannon J; Miller RG
    Int Immunol; 2003 Mar; 15(3):411-6. PubMed ID: 12618485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-Dependent Induction of Clr-b during Mouse Cytomegalovirus Infection Protects Bystander Cells from Natural Killer Cells via NKR-P1B-Mediated Inhibition.
    Kirkham CL; Aguilar OA; Yu T; Tanaka M; Mesci A; Chu KL; Fine JH; Mossman KL; Bremner R; Allan DSJ; Carlyle JR
    J Innate Immun; 2017; 9(4):343-358. PubMed ID: 28288457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Inhibitory NKR-P1B:Clr-b Recognition Axis Facilitates Detection of Oncogenic Transformation and Cancer Immunosurveillance.
    Tanaka M; Fine JH; Kirkham CL; Aguilar OA; Belcheva A; Martin A; Ketela T; Moffat J; Allan DSJ; Carlyle JR
    Cancer Res; 2018 Jul; 78(13):3589-3603. PubMed ID: 29691253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.